Floatz logo

Marijuana

Lumbar Radiculopathy

University of California, San DiegoEarly Phase 1Active
C
39/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
24/ 100
Competitive Position
95/ 100

Competitive context

4 Active assets in the Lumbar Radiculopathy cohort.

Asset / SponsorPhaseRating
Triamcinalone
University of Miami
Phase 4BB
Pentoxifylline
St Joseph University, Beirut, Lebanon
Phase 4BB
IBUPROFEN
St Joseph University, Beirut, Lebanon
Phase 4BB
DEXAMETHASONE
University of Miami
Phase 4BB
Naltrexone
Allodynic Therapeutics, Inc
Phase 2B
sx600
SpineThera Australia PTY LTD
Phase 1/2CCC
Hyaluronidase
EPC Education s.r.o.
N/AD

Same molecule, other indications

Marijuana is also rated in:

CannabisDormant
BB
Indicative ·
71 / 100
View asset →
HIV NeuropathyDormant
BB
Indicative ·
65 / 100
View asset →
Diabetic Peripheral Neuropathic PainDormant
B
Indicative ·
62 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →